Clinical trials still represent the gold standard in testing the safety and efficacy of new and existing treatments. However, developing regions, including sub-Saharan Africa, remain underrepresented in pharmaceutical-industry-sponsored trials for several reasons, including theand unethical behaviour. Corruption, whether actual or perceived, is one of many issues that have precluded the implementation of more industry-sponsored clinical trials in this region.
Africans, and indeed other vulnerable populations, must be recognised as partners rather than pawns. The second-most populous continent deserves better representation in key epidemiological studies. Covid-19 vaccines are best studied in populations that are worst affected by the outbreak. The French doctors in question need intensive re-education after they publicly apologise and retract their offensive statements. The future of vaccine testing in vulnerable populations — its success or failure — is entirely up to us all. These are unprecedented times, and the role of media to tell and record the story of South Africa as it develops is more important than ever. But it comes at a cost.
The Mail & Guardian is a proud news publisher with roots stretching back 35 years. We’ve survived thanks to the support of our readers, we will need you to help us get through this.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ewnupdates - 🏆 30. / 53 Read more »
Source: mailandguardian - 🏆 2. / 92 Read more »